MiraCradle

Gurugram, India Founded: 1994 • Age: 32 yrs Listed
Affordable cooling devices are provided for newborn therapeutic hypothermia.

About MiraCradle

MiraCradle is a publicly listed company based in Gurugram (India) founded in 1994. Affordable cooling devices are provided for newborn therapeutic hypothermia. MiraCradle has raised $2.88 million across 6 funding rounds from investors including Tata Capital, CUMI and Samit Jain. The company has 33 employees. MiraCradle was last valued at $20.43 million in October 2021. Its Indian entity Carborundum Universal Limited reported revenue of β‚Ή5,309 Cr. Its focus areas include Life Sciences, Pediatrics, Medical Devices and Therapeutics.

Company details

MiraCradle - NeoNate Cooler is an affordable cooling device to induce therapeutic hypothermia among newborns suffering from birth asphyxia. It has been developed by Pluss Polymers in collaboration with CMC Vellore. The product gives the precise temperature control of 33-34C for a period of 72 hours with minimal manual supervision and no requirement of constant electricity supply. 17 hospitals across India are currently using the product with 70 babies treated using it till date. Winner of CII Industrial Innovation Award.

  • Headquarters Gurugram, India
  • Employees 33
  • Stage Public
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website miracradle.com
  • Social LinkedIn X Facebook
  • Legal Name Carborundum Universal Limited
  • Date of Incorporation 21 Apr, 1954
  • Jurisdiction Chennai, Tamil Nadu, India
Operational Areas
Key Metrics
  • Market Cap
    ₹20,663 Cr

    CARBORUNIV · NSE

  • Share Price
    ₹1,047.00

    -3.47% today

  • Revenue
    ₹5,206 Cr

    FY 2025-26 · +6.4% YoY

  • EBITDA
    ₹444 Cr

    Margin 8.5%

  • Net Profit
    ₹257 Cr

    FY 2025-26 · -29.0% YoY

  • P/E (TTM)
    76.6x

    P/B 5.4x

  • ROE
    6.2%

    ROCE 10.7%

  • Debt / Equity
    0.08

    Interest cover 9.5x

  • Total Equity Funding
    $2.88M (USD)

    in 6 rounds

  • Latest Funding Round
    $2.68M (USD), Series B

    Oct 2021

  • Investors
  • Employee Count
    33

Funding Insights of MiraCradle

MiraCradle has successfully raised a total of $2.88M across 6 strategic funding rounds. The most recent funding activity was a Series B round of $2.68 million completed in October 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $2.88M
  • Total Rounds 6
  • Last Round Series B β€” $2.68M
  • First Round $2.69M

    (Nov 2012)

  • Investors Count 7

All 6 funding rounds of MiraCradle with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2021$2.68MSeries B$20.43MCUMI
–
Dec 2019$28,157Unspecified$16.1MTata Capital
–
Oct 2019$81,945Angel Round$β€’β€’β€’β€’β€’Samit Jain
Aug 2018$116,557Angel Round$β€’β€’β€’β€’β€’Rajeev Kochar
Jun 2015$1.6MUnspecified$β€’β€’β€’β€’β€’Tata Capital
–
Nov 2012$2.69MUnspecified$β€’β€’β€’β€’β€’Tata Capital
–
Valuation history
DateValuationStage
Oct 2021$20.43Mβ€’β€’β€’β€’β€’β€’β€’β€’
Dec 2019$16.1Mβ€’β€’β€’β€’β€’β€’β€’β€’
Oct 2019$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Aug 2018$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Jun 2015$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Nov 2012$β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’
Premium access

Full valuation and stage history of MiraCradle

Every valuation point, the growth-stage changes (minicorn, soonicorn, unicorn) and the dates behind them require an active premium plan.

  • All valuation points
  • Stage changes
  • Dates
  • Exports

Verified entity values are shown only after access is granted.

Last known valuation $20.43M (Oct 2021). 7 investors in total: 2 institutional and 5 angel.

Investors in MiraCradle

MiraCradle has secured backing from 7 investors, including institutional and angel investors. Prominent investors backing the company include Tata Capital, CUMI and Samit Jain.

All
Institutional
Angel
InvestorDescriptionFounded YearDomainLocation
Abrasives and ceramic fibers are manufactured by CUMI in India.
1954cumi-murugappa.comChennai, India
Diversified non-banking financial services are provided by Tata Capital.
2007tatacapital.comMumbai, India

Samit Jain

unknown_bc4b913fb1384741b

Rajeev Kochar

unknown_e57521ea4a434b559

Devendra Jain

Angel investor and entrepreneur, founder of Atishay Limited, focusing on tech startups.
unknown_e23b01d696df4f9fa

Ankit Jhanwar

unknown_1bd67e637062417fa

Anil Mehta

Angel investor and entrepreneur, co-founder of BuildSupply, focused on tech startups
unknown_d93a4bcc9126487e8
Premium access

Investor details for MiraCradle

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Carborundum Universal Limited (MiraCradle)

Carborundum Universal Limited is the primary company behind MiraCradle. The boards of the 2 registered companies of MiraCradle currently have 9 directors; the longest-serving is Muthiah Murugappan Murugappan, appointed in 1996. 35 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Muthiah Murugappan Murugappan
DIN 00170478
Director17 Oct 199630 yrsCarborundum Universal Limited
Samit Jain
DIN 00126512
Managing Director30 Nov 200025 yrs 11 moPluss Advanced Technologies Limited
Sujjain Suresh Talwar
DIN 01756539
Director09 May 20179 yrs 5 moCarborundum Universal Limited
Rangarajan Sridharan
DIN 01814413
Director06 Oct 20215 yrs 1 moPluss Advanced Technologies Limited, Carborundum Universal Limited
Manoj Agarwal
DIN 09415311
Director14 Dec 20214 yrs 10 moPluss Advanced Technologies Limited
Viji Sriram
DIN 03630636
Director01 Aug 20242 yrs 3 moCarborundum Universal Limited
Usha Rajeev
DIN 05018645
Director01 Aug 20242 yrs 3 moCarborundum Universal Limited
Muthiah Murugappan
DIN 07858587
Director01 Aug 20242 yrs 3 moCarborundum Universal Limited
Bala Venkatesh Varma Datla
DIN 11564227
Director04 Mar 20268 moCarborundum Universal Limited

IPO & Listings of MiraCradle

MiraCradle is a publicly listed company on the NSE with ticker symbol CARBORUNIV in India, operating in the Capital Goods-Non Electrical Equipment sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

  • Listed onNSE: CARBORUNIV
  • Listed entityCarborundum Universal Limited
  • Exchange sectorCapital Goods-Non Electrical Equipment

Financials of MiraCradle

Exchange-reported figures of Carborundum Universal Limited, the listed company behind MiraCradle (NSE: CARBORUNIV).

Financial Highlights

FY 2025-26 Β· Consolidated
Revenue
₹5,206 Cr
+6.4% YoY
EBITDA
₹444 Cr
-26.9% YoY
Profit After Tax
₹257 Cr
-29.0% YoY
Net Worth
₹3,900 Cr
+10.5% YoY
Total Assets
₹4,503 Cr
+13.5% YoY
Total Debt
₹413 Cr
+90.7% YoY

Revenue vs Net Profit ₹ Cr

Margin trends

Financial summary ₹ Cr

MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue5,2064,8944,7024,6543,3252,6322,599
Revenue growth+6.4%+4.1%+1.0%+40.0%+26.3%+1.3%-
EBITDA444608739652537441399
EBITDA margin+8.5%+12.4%+15.7%+14.0%+16.1%+16.7%+15.3%
Profit before tax282468650580477395351
Net profit257362463399336292269
Net profit margin+4.9%+7.4%+9.8%+8.6%+10.1%+11.1%+10.4%
EPS (β‚Ή)10.2215.3724.2421.8017.5615.0014.38
Balance sheet
Total assets4,5033,9673,5133,3302,7182,2521,986
Net worth3,9003,5293,1262,8212,3722,1361,863
Total debt41321617227723256.7466.11
Cash & bank700381558400352689294
Net working capital2,0731,7871,5901,4841,0841,283980
Cash flow
Cash from operations367304602430245451407
Cash from investing(167)(371)(229)(248)(465)(266)(105)
Cash from financing119(110)(214)(133)89.43(66.19)(135)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,4691,4271,3981,2911,2981,2191,2171,255
Revenue growth (YoY)+13.2%+17.0%+14.9%+2.8%+6.0%+1.8%--
Other income25.0455.4231.3721.7922.7626.9617.6327.01
EBITDA1041359.6015715612114672.86
EBITDA margin+7.1%+9.6%+0.7%+12.3%+12.2%+10.0%+12.2%+5.9%
Depreciation64.3365.5164.5361.1462.2358.8956.0652.60
Interest6.575.806.254.594.433.493.133.85
Profit before tax58.02119(29.81)11311385.8310543.42
Tax45.9838.8710.2040.0038.2525.4474.635.81
Net profit12.0480.34(40.01)73.1674.2660.3930.1037.61
EPS (β‚Ή)0.664.04(0.93)4.013.943.271.731.82
MetricsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Income statement
Revenue3,0632,8282,6332,5102,2151,6721,651
Revenue growth+8.3%+7.4%+4.9%+13.3%+32.5%+1.3%-
EBITDA481467494464370250260
EBITDA margin+15.7%+16.5%+18.8%+18.5%+16.7%+15.0%+15.7%
Profit before tax525425463432346244240
Net profit417322351313254190187
Net profit margin+13.6%+11.4%+13.3%+12.5%+11.5%+11.4%+11.4%
EPS (β‚Ή)21.8516.8918.4117.4213.409.7010.10
Balance sheet
Total assets2,9332,5792,3162,1231,9151,5441,375
Net worth2,9102,5582,2982,0071,7411,5351,367
Total debt0.000.000.021041630.250.55
Cash & bank20588.2017512.4618.24465163
Net working capital953757676521481850619
Cash flow
Cash from operations302190401344198271231
Cash from investing(110)(206)(77.08)(212)(548)(214)(30.84)
Cash from financing(74.09)(70.87)(161)(138)111(25.81)(86.45)
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue921855855780720707699738
Revenue growth (YoY)+27.9%+21.0%+22.3%+5.8%+0.4%+5.0%--
Other income2.4215.0739.482.368.0788.599.282.11
Total expenses796729715643617606607610
EBITDA12512614113710310192.29128
EBITDA margin+13.7%+14.9%+16.6%+17.8%+14.4%+14.4%+13.4%+17.6%
Depreciation26.9325.9224.0523.8823.6723.0120.5820.37
Interest2.060.480.160.000.000.000.160.01
Profit before tax98.6811515611587.1616680.83109
Tax26.3926.7133.4830.7622.8221.4819.5328.93

Financial Statements

Figures in ₹ Cr; negatives in brackets. Updated 06 Nov 2026
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue1,4691,4271,3981,2911,2981,2191,2171,255
Revenue growth (YoY)+13.2%+17.0%+14.9%+2.8%+6.0%+1.8%--
Other income25.0455.4231.3721.7922.7626.9617.6327.01
EBITDA1041359.6015715612114672.86
EBITDA margin+7.1%+9.6%+0.7%+12.3%+12.2%+10.0%+12.2%+5.9%
Depreciation64.3365.5164.5361.1462.2358.8956.0652.60
Interest6.575.806.254.594.433.493.133.85
Profit before tax58.02119(29.81)11311385.8310543.42
Tax45.9838.8710.2040.0038.2525.4474.635.81
Net profit12.0480.34(40.01)73.1674.2660.3930.1037.61
EPS (β‚Ή)0.664.04(0.93)4.013.943.271.731.82
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue5,2064,8944,7024,6543,3252,6322,599
Revenue growth+6.4%+4.1%+1.0%+40.0%+26.3%+1.3%-
Other income10386.2012113960.1257.0062.78
Total expenses4,7624,2873,9634,0022,7882,1912,200
Employee cost949858772688416345341
EBITDA444608739652537441399
EBITDA margin+8.5%+12.4%+15.7%+14.0%+16.1%+16.7%+15.3%
Depreciation24721219118711599.45105
Interest18.7613.9718.3423.535.643.586.33
Profit before tax282468650580477395351
Tax11416917413812710275.55
Net profit257362463399336292269
Net profit margin+4.9%+7.4%+9.8%+8.6%+10.1%+11.1%+10.4%
EPS (β‚Ή)10.2215.3724.2421.8017.5615.0014.38
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital19.0519.0419.0318.9926.7723.9423.17
Reserves & surplus3,8813,5103,1072,8022,3452,1131,839
Shareholders' funds (net worth)3,9003,5293,1262,8212,3722,1361,863
Minority interest10814713912885.9446.4245.54
Secured loans13997.0893.431317.873.879.40
Unsecured loans27311978.4614622452.8756.71
Total debt41321617227723256.7466.11
Total liabilities4,5033,9673,5133,3302,7182,2521,986
Assets
Gross block3,4522,9362,5582,3821,6761,3501,227
Net block1,9061,7161,5551,5271,006777748
Capital work in progress14111884.0787.4757.7028.0238.65
Investments199201172161138127189
Inventories1,1171,055850899691461508
Sundry debtors891766679627485478402
Cash & bank balances700381558400352689294
Loans & advances13219881.6299.5212182.2969.47
Total current assets2,8412,4002,1692,0261,6481,7091,273
Total current liabilities768613578542564426293
Net working capital2,0731,7871,5901,4841,0841,283980
Total assets4,5033,9673,5133,3302,7182,2521,986
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash378555396348478360192
Net cash from operating activities367304602430245451407
Net cash from investing activities(167)(371)(229)(248)(465)(266)(105)
Net cash from financing activities119(110)(214)(133)89.43(66.19)(135)
Net change in cash320(177)15948.87(131)119168
Closing cash700381558400352689294
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+6.4%+4.1%+1.0%+40.0%+26.3%+1.3%-
EBITDA growth-26.9%-17.8%+13.3%+21.5%+21.8%+10.6%-
PBT growth-39.8%-28.1%+12.1%+21.7%+20.8%+12.6%-5.0%
Net income growth-29.0%-21.7%+16.1%+18.8%+14.7%+8.6%-
Revenue CAGR (3Y)+3.8%+13.8%+21.3%+21.4%+7.3%+3.5%+7.2%
EBITDA CAGR (3Y)-12.0%+4.2%+18.8%+17.8%+7.0%+3.4%+6.0%
Profitability & leverage
Net income margin+3.2%+6.1%+10.1%+9.5%+10.5%+11.1%+10.6%
Return on capital employed+10.7%+16.4%+20.3%+20.7%+19.9%+19.2%+18.9%
Return on net worth+6.2%+11.1%+16.0%+17.0%+15.6%+14.7%+15.4%
Debt / equity0.080.060.080.100.060.030.04
Long-term debt / equity0.030.030.030.020.010.010.00
Interest cover9.493.533.355.071.341.052.15
Efficiency & per share
Fixed asset turnover1.631.781.902.292.202.042.25
Inventory turnover4.795.145.385.865.785.445.00
Debtors turnover6.286.777.208.376.915.995.68
EPS (β‚Ή)10.2215.3724.2421.8017.5615.0014.38
Dividend per share (β‚Ή)4.004.004.003.503.503.002.75
Book value per share (β‚Ή)204.60185.18164.16148.50124.50112.4398.11
ParticularsSep 2026Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024
Revenue921855855780720707699738
Revenue growth (YoY)+27.9%+21.0%+22.3%+5.8%+0.4%+5.0%--
Other income2.4215.0739.482.368.0788.599.282.11
Total expenses796729715643617606607610
EBITDA12512614113710310192.29128
EBITDA margin+13.7%+14.9%+16.6%+17.8%+14.4%+14.4%+13.4%+17.6%
Depreciation26.9325.9224.0523.8823.6723.0120.5820.37
Interest2.060.480.160.000.000.000.160.01
Profit before tax98.6811515611587.1616680.83109
Tax26.3926.7133.4830.7622.8221.4819.5328.93
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Revenue3,0632,8282,6332,5102,2151,6721,651
Revenue growth+8.3%+7.4%+4.9%+13.3%+32.5%+1.3%-
Other income13838.8745.4656.8141.9556.0747.33
Total expenses2,5812,3602,1392,0461,8461,4221,392
Employee cost313286254232211195192
EBITDA481467494464370250260
EBITDA margin+15.7%+16.5%+18.8%+18.5%+16.7%+15.0%+15.7%
Depreciation94.6180.6372.6574.4965.0461.4366.98
Interest0.160.174.1515.040.970.270.35
Profit before tax525425463432346244240
Tax10910411310191.0560.4948.22
Net profit417322351313254190187
Net profit margin+13.6%+11.4%+13.3%+12.5%+11.5%+11.4%+11.4%
EPS (β‚Ή)21.8516.8918.4117.4213.409.7010.10
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Equity & liabilities
Share capital19.0519.0419.0318.9918.9918.9618.94
Reserves & surplus2,8912,5392,2781,9881,7221,5161,348
Shareholders' funds (net worth)2,9102,5582,2982,0071,7411,5351,367
Secured loans0.000.000.0038.000.000.000.00
Unsecured loans0.000.000.0266.101630.250.55
Total debt0.000.000.021041630.250.55
Total liabilities2,9332,5792,3162,1231,9151,5441,375
Assets
Gross block1,4381,2311,097998885809755
Net block713590527486435418422
Capital work in progress10874.2847.4546.5018.0211.1512.22
Investments1,0991,1001,0391,048968251307
Inventories467442361380400295326
Sundry debtors545452379390331318259
Cash & bank balances20588.2017512.4618.24465163
Loans & advances76.1062.2233.9148.9877.3065.2855.84
Total current assets1,2931,0449498318271,144805
Total current liabilities340287273310346293186
Net working capital953757676521481850619
Total assets2,9332,5792,3162,1231,9151,5441,375
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Opening cash85.801739.9215.84255223109
Net cash from operating activities302190401344198271231
Net cash from investing activities(110)(206)(77.08)(212)(548)(214)(30.84)
Net cash from financing activities(74.09)(70.87)(161)(138)111(25.81)(86.45)
Net change in cash117(86.76)163(5.92)(239)31.76114
Closing cash20588.2017512.4618.24465163
ParticularsFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21FY 2019-20
Growth
Sales growth+8.3%+7.4%+4.9%+13.3%+32.5%+1.3%-
EBITDA growth+3.0%-5.5%+6.5%+25.6%+47.8%-3.7%-
PBT growth+23.4%-8.2%+7.3%+24.9%+41.4%+2.1%-3.4%
Net income growth+29.3%-8.2%+12.3%+22.9%+34.0%+1.3%-
Revenue CAGR (3Y)+6.9%+8.5%+16.3%+15.0%+7.5%+1.9%+5.5%
EBITDA CAGR (3Y)+1.2%+8.1%+25.5%+21.4%+7.5%+0.1%+7.0%
Profitability & leverage
Net income margin+13.6%+11.4%+13.3%+13.2%+11.5%+11.0%+11.6%
Return on capital employed+19.1%+17.4%+21.1%+22.2%+20.1%+16.8%+18.1%
Return on net worth+15.2%+13.3%+16.3%+17.7%+15.6%+12.7%+14.5%
Debt / equity0.000.000.020.070.050.000.00
Long-term debt / equity0.000.000.000.000.000.000.00
Interest cover0.040.040.983.860.320.140.18
Efficiency & per share
Fixed asset turnover2.302.432.522.672.622.142.33
Inventory turnover6.747.047.116.446.375.384.96
Debtors turnover6.156.816.856.976.835.805.60
EPS (β‚Ή)21.8516.8918.4117.4213.409.7010.10
Dividend per share (β‚Ή)4.004.004.003.503.503.002.75
Book value per share (β‚Ή)152.62134.22120.63105.5191.5680.8372.18

Timeline of MiraCradle

4 dated milestones of MiraCradle across 27 years, from founding to its latest funding, stage changes and deals.

  1. Founded MiraCradle is founded.
  2. Funding First funding round of $2.7M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Series B, of $2.7M.
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Miracradle

CARBORUNIV: Q2 REVENUE 14.7B RUPEES VS 12.98B (YOY)
Exchange Update β€’ 4 days ago
CARBORUNIV: Q2 CONS NET PROFIT 125M RUPEES VS 745.1M (YOY)
Exchange Update β€’ 4 days ago
CARBORUNIV: Q2 EBITDA 1.1B RUPEES VS 1.56B (YOY); Q2 EBITDA MARGIN 7.52% VS 12.05% (YOY)
Exchange Update β€’ 4 days ago
Premium access

Complete news archive for MiraCradle

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about MiraCradle

MiraCradle was founded in 1994 and raised its 1st funding round 18 years after it was founded.

MiraCradle is headquartered in Gurugram, India. It is registered at Gurugram, Haryana, India.

MiraCradle is a funded company, having raised a total of $2.88M across 6 funding rounds to date. The company's 1st funding round was a Unspecified of $2.69M, raised on Nov 2012.

MiraCradle has 33 employees.

The primary company behind MiraCradle, Carborundum Universal Limited, reported revenue of β‚Ή5,309 Cr for FY 0000, up 6% year on year.

MiraCradle - NeoNate Cooler is an affordable cooling device to induce therapeutic hypothermia among newborns suffering from birth asphyxia. It has been developed by Pluss Polymers in collaboration with CMC Vellore. The product gives the precise temperature control of 33-34C for a period of 72 hours with minimal manual supervision and no requirement of constant electricity supply. 17 hospitals across India are currently using the product with 70 babies treated using it till date. Winner of CII Industrial Innovation Award.

Yes, MiraCradle is publicly traded on NSE under the ticker symbol CARBORUNIV.

MiraCradle has 7 investors. Key investors include Tata Capital, CUMI, Samit Jain, Rajeev Kochar, and Devendra Jain.

The valuation of MiraCradle is $20.43M as of Oct 2021.

MiraCradle is associated with 2 legal entities: Carborundum Universal Limited, Pluss Advanced Technologies Limited.

The legal entities of MiraCradle currently have 11 directors, including Manoj Agarwal, Rangarajan Sridharan, Samit Jain and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available